US-based ResearchDx has announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets.
As part of this initiative,ResearchDx will be exhibiting at the 2014 Arab Health Congress in Dubai,UAE,held 27 January to 30 January,at the Dubai International Convention and Exhibition Centre.
ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain Clinical Laboratory licensure and accreditations,such as ISO15189,College of American Pathologists(CAP)accreditation and US International CLIA certification.
ResearchDx principal and co-founder Dr Philip Cotter noted internationally recognized clinical laboratory accreditations provide its clients with a competitive edge.
"These accreditations and licensures have enabled our clients to successfully compete for multi-national based clinical trial studies and demonstrate the internationally recognized quality of their laboratories,"Dr Cotter added.
ResearchDx co-founder and principal Dr Mathew Moore noted the company is proud to be involved as an exhibitor at Arab Health.
"In addition,as the leading Contract Diagnostics Organization,ResearchDx can provide strategic partnerships to Middle Eastern biopharmaceutical and diagnostic companies looking to develop companion diagnostics or in vitro diagnostic products for the local,US or European markets.We provide a full range of companion diagnostics and in vitro diagnostics services"Dr Moore added.
